title: Differentiation of HL-60 cells into cells with the osteoclast phenotype.
abstract: The osteoclast is the unique multinucleated cell that is responsible for bone degradation in both physiological and pathological circumstances. However, knowledge of the lineage of this inaccessible cell, the nature of its precursors, and the regulation of its formation and activation is limited and controversial. Here we show that the human promyelocytic cell line HL-60 has the potential, under the appropriate culture conditions, to differentiate into cells that have morphological and functional characteristics of osteoclasts, including multinucleation, presence of tartrate-resistant acid phosphatase activity, cross-reactivity with monoclonal antibodies that preferentially recognize osteoclasts, and capacity to resorb bone and respond to calcitonin. The multinucleated cells also contain high affinity receptors to calcitonin, in contrast to wild-type undifferentiated HL-60 cells. These data suggest that osteoclasts share a common precursor with hematopoietic cells. These undifferentiated and differentiated HL-60 cells should provide a unique model for study of the cell biology of human osteoclast differentiation, allowing molecular biological and biochemical studies heretofore not possible.
authors.affiliation: Department of Medicine, University of Texas Health Science Center, San Antonio 78284-7877.
authors.forename: T
authors.initials: T
authors.lastname: Yoneda
authors.forename: M M
authors.initials: MM
authors.lastname: Alsina
authors.forename: J L
authors.initials: JL
authors.lastname: Garcia
authors.forename: G R
authors.initials: GR
authors.lastname: Mundy
mesh_terms: D001862:Bone Resorption; D002116:Calcitonin / Q000378:metabolism / Q000494:pharmacology; D002117:Calcitriol / Q000494:pharmacology; D002294:Carcinoma, Squamous Cell; D002454:Cell Differentiation / Q000187:drug effects; D002467:Cell Nucleus / Q000648:ultrastructure; D006412:Hematopoietic Stem Cells / Q000166:cytology; D006801:Humans; D007124:Immunoenzyme Techniques; D015473:Leukemia, Promyelocytic, Acute / Q000473:pathology*; D010010:Osteoclasts / Q000473:pathology* / Q000502:physiology; D010641:Phenotype; D018003:Receptors, Calcitonin; D011956:Receptors, Cell Surface / Q000378:metabolism; D014407:Tumor Cells, Cultured
chemical_list: D018003:Receptors, Calcitonin; D011956:Receptors, Cell Surface; C028815:salmon calcitonin; D002116:Calcitonin; D002117:Calcitriol